Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Analyst Ratings
  • Dividends
  • General
  • Health Care
  • Markets
  • News
  • Pre-Market Outlook
  • Price Target
  • Trading Ideas

Wall Street’s Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields

By Lisa Levin
October 12, 9:19 AM
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

BMY

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • News

Walgreens Q4 Profit, Annual Outlook Falls Short Of Expectations On Lower Demand For Covid Vaccines, Tests

By Vandana Singh
October 12, 8:40 AM
Walgreens Boots Alliance Inc's (NASDAQ: WBA) Q4 FY23 sales increased 9.2% Y/Y to $35.4 billion, up 8.3% on a constant currency basis, beating the consensus of $34.82 bill

WBA

Read More
1 minute read
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks

500% Gain In Premarket Session – Here’s Why Precision Medicine OpGen Stock Is Soaring

By Vandana Singh
October 12, 8:36 AM
OpGen Inc (NASDAQ: OPGN) stock is trading higher following two SEC filings from the precision medicine company.

OPGN

Read More
1 minute read
  • General
  • Health Care
  • Legal
  • News

Will Illumina Give Up Cancer Test Maker Grail? Mulls $8B Acquisition’s Fate Amid Antitrust Pressure

By Vandana Singh
October 12, 7:38 AM
Illumina Inc (NASDAQ: ILMN) reportedly said it will divest its controversial acquisition of Grail as expeditiously as possible if the life sciences company loses either of the final appeals in U.S. or European courts.

ILMN

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News

Novo Nordisk’s Popular Diabetes Drug Ozempic Faces Counterfeit Threat in Germany

By Vandana Singh
October 12, 7:36 AM
Germany's federal drug regulator, BfArM, has warned pharmacies and drug distributors in response to discovering counterfeit batches of Novo Nordisk's (NYSE: NVO) diabetes 

NVO

Read More
2 minute read
  • Analyst Color
  • Biotech
  • Equities
  • Health Care
  • Long Ideas
  • News
  • Specialty ETFs
  • Top Stories
  • Trading Ideas

Eli Lilly To Fly Higher? Fund Manager Gary Black Envisions Blockbuster Potential For Diabetes Drug Mounjaro

By Shanthi Rexaline
October 12, 4:40 AM
Lilly stock has been on a tear this year, thanks to the huge potential its GLP-1 agonist Mounjaro promises.

FFND

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Price Target
  • Small Cap
  • Trading Ideas

Akero Therapeutics’ Lead Candidate Potential: Analyst Unpacks Complicated Regulatory Path Forward

By Vandana Singh
October 11, 3:35 PM
Tuesday, Akero Therapeutics Inc (NASDAQ: AKRO) reported a 36-week analysis of SYMMETRY, a 96-week Phase 2b study of efruxifermin (EFX) in patients with compensated cirrhosis (F4) due to nonalcoholic steatohepatitis (NASH).

AKRO

Read More
2 minute read
  • Analyst Ratings
  • Downgrades
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Trading Ideas

Analysts Downgrade Heart Devices Focused Silk Road Medical, Cite Uncertain Prospects

By Vandana Singh
October 11, 3:24 PM
Tuesday, Silk Road Medical Inc (NASDAQ: SILK) reported interim preliminary Q3 revenue expectation of approximately $44.4 million, up 19% Y/Y, lower than the 

SILK

Read More
2 minute read
  • General
  • Health Care
  • Large Cap
  • News

Is There A Blood Test for Alzheimer’s? Progress Underway, But Not Quite Ready

By Vandana Singh
October 11, 2:27 PM
Blood tests for diagnosing Alzheimer's disease are eagerly awaited, but it may be a couple of years before they become a routine diagnostic tool. While several blood tests for Alzheimer's diagnosis are in development, none are approved by regulators or insurance reimbursement. 

BIIB

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Why Is Immuno-Oncology Focused Phio Pharmaceuticals Stock Trading Higher Today?

By Vandana Singh
October 11, 2:24 PM
Phio Pharmaceuticals Corp (NASDAQ: PHIO) shares are trading higher after the company announced the poster presentation of two preclinical studies of its INTASYL compound PH-894 at the AACR-NCI-EORTC International Conference on Molecular 

PHIO

Posts pagination

Previous 1 … 141 142 143 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service